Management to provide updates on recent developments including diagnostic billing, market access & growth plans HOUSTON, Sept. 25, 2026 (GLOBE NEWSWIRE) — CNSide Diagnostics, LLC, a wholly-owned subsidiary of Cerenome, Inc. (Nasdaq: CNSY) (“Cerenome” or the “Company”), today announced that…